e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Non-tuberculous mycobacteria pulmonary infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Transitional change of the relationship between clinical efficacy of treatment for pulmonary MAC disease and drug-sensitivity test for MAC isolated
Y. Kobashi, M. Abe, K. Mouri, Y. Obase, N. Miyashita, M. Oka (Kurashiki, Japan)
Source:
Annual Congress 2011 - Non-tuberculous mycobacteria pulmonary infections
Session:
Non-tuberculous mycobacteria pulmonary infections
Session type:
Oral Presentation
Number:
3398
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Kobashi, M. Abe, K. Mouri, Y. Obase, N. Miyashita, M. Oka (Kurashiki, Japan). Transitional change of the relationship between clinical efficacy of treatment for pulmonary MAC disease and drug-sensitivity test for MAC isolated. Eur Respir J 2011; 38: Suppl. 55, 3398
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Clinical utility of serum anti-mycobacterium avium complex (MAC) antibody for diagnosis of MAC lung disease in asymptomatic patients with radiologically suspected MAC lung disease: A pilot study
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Year: 2015
Clinical manifestation and pulmonary function test after post tuberculosis treatment
Source: International Congress 2018 – Pulmonary tuberculosis: long term complications, rehabilitation and challenges
Year: 2018
The relationship between clinical prediction markers, radiological characteristics and 6 month outcome following acute pulmonary embolism
Source: Annual Congress 2010 - Clinical management of venous thrombosis, pulmonary embolism and thrombophilia
Year: 2010
Evaluation of the efficacy and safety of moxifloxacin in the treatment of drug-resistant pulmonary tuberculosis; a clinical trial
Source: Annual Congress 2008 - Multidrug-resistant and the emerging threat of extensively drug-resistant tuberculosis
Year: 2008
Does a predominant clinical COPD phenotype predict different outcome responses to pulmonary rehabilitation?
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012
Comparing outcomes internationally in pulmonary sarcoidosis: PFT change by scadding stage
Source: International Congress 2017 – Respiratory epidemiology: from sarcoidosis to respiratory infections and tuberculosis
Year: 2017
The use of FENO in COPD: the relationship to pulmonary function tests and its importance in differential diagnosis.
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
Outcome of shorter treatment after culture conversion in non-cavitary MAC lung disease
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019
Managing tuberculosis in chronic kidney disease: An evaluation of patient treatment regimens
Source: Annual Congress 2011 - Tuberculosis in special populations
Year: 2011
Evaluation of the efficacy and safety of levofloxacin in the treatment of resistant pulmonary tuberculosis; a clinical trial
Source: Eur Respir J 2002; 20: Suppl. 38, 546s
Year: 2002
Effects and feasibility of different types of endurance training in patients with end stage lung disease before lung transplantation
Source: Annual Congress 2011 - The best abstracts in rehabilitation and chronic care 2011 (sponsored by Nutricia Advanced Medical Nutrition)
Year: 2011
Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations.
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018
Late-breaking abstract: Evaluation of CRP, PCT, clinical pulmonary infection score and pneumonia severity scores for the diagnosis and prognosis of nursing home acquired pneumonia
Source: Annual Congress 2011 - Early diagnosis in primary care
Year: 2011
Which treatment for which patient with an acute exacerbation of pulmonary hypertension?
Source: Annual Congress 2010 - The acute right heart syndrome in the intensive care unit: a hidden world?
Year: 2010
The relationship between extension of disease in the patients with smear positive pulmonary tuberculosis and hepatotoxicity
Source: Eur Respir J 2006; 28: Suppl. 50, 6s
Year: 2006
Association of genetic markers with clinical course of patients with pulmonary tuberculosis with drug resistance
Source: Eur Respir J 2007; 30: Suppl. 51, 203s
Year: 2007
Endurance time is the most sensitive exercise measurement for evaluating pulmonary rehabilitation efficacy in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2012 - The latest insights in pulmonary rehabilitation
Year: 2012
Study of states of leukocytes in blood of pulmonary tuberculosis patients with different efficacy of treatment.
Source: Virtual Congress 2020 – Tuberculosis and society
Year: 2020
Efficacy and safety of antibiotic treatment of stable COPD
Source: Annual Congress 2010 - Treatment of bronchial infection: beyond the exacerbations
Year: 2010
Efficacy of different preoperational treatment in patients with destructive pulmonary TB
Source: Eur Respir J 2005; 26: Suppl. 49, 688s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept